The Gut–Brain Axis and the Microbiome: Mechanisms and Clinical Implications

Clinical Gastroenterology and Hepatology

Volumn 17, Issue 2, 2019, Pages 322-332

  Osadchiy, Vadim ^a   Martin, Clair R ^a   Mayer, Emeran A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diet; Early Life Influences; Irritable Bowel Syndrome

Indexed keywords

PROBIOTIC AGENT; BIOLOGICAL FACTOR;

BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; CORRELATIONAL STUDY; DIET; DIGESTIVE TRACT PARAMETERS; FOOD INTAKE; HUMAN; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; NERVOUS SYSTEM PARAMETERS; NONHUMAN; OBESITY; ORGANISMAL INTERACTION; PRENATAL PERIOD; REVIEW; SIGNAL TRANSDUCTION; STRESS; BRAIN; DRUG EFFECT; GASTROINTESTINAL TRACT; METABOLISM; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY;

BIOLOGICAL FACTORS; BRAIN; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HOST MICROBIAL INTERACTIONS; HUMANS; MICROBIOTA;

EID: 85059157933     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2018.10.002     Document Type: Review

References (135)

1. Tolhurst, G., Heffron, H., Lam, Y.S., et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61 (2012), 364–371.
2. Wikoff, W.R., Anfora, A.T., Liu, J., et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A 106 (2009), 3698–3703.
3. Yano, J.M., Yu, K., Donaldson, G.P., et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161 (2015), 264–276.
4. Samuel, B.S., Shaito, A., Motoike, T., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A 105 (2008), 16767–16772.
5. Haghikia, A., Jorg, S., Duscha, A., et al. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity 43 (2015), 817–829.
6. Bravo, J.A., Forsythe, P., Chew, M.V., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108 (2011), 16050–16055.
7. Goehler, L.E., Gaykema, R.P., Opitz, N., et al. Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun 19 (2005), 334–344.
8. Marcelin, G., Jo, Y.H., Li, X., et al. Central action of FGF19 reduces hypothalamic AGRP/NPY neuron activity and improves glucose metabolism. Mol Metab 3 (2014), 19–28.
9. Ryan, K.K., Kohli, R., Gutierrez-Aguilar, R., et al. Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats. Endocrinology 154 (2013), 9–15.
10. Perry, R.J., Lee, S., Ma, L., et al. FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic-pituitary-adrenal axis. Nat Commun, 6, 2015, 6980.
11. Bala, V., Rajagopal, S., Kumar, D.P., et al. Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac/PLC-epsilon pathway and modulated by endogenous H2S. Front Physiol, 5, 2014, 420.
12. Cani, P.D., Lecourt, E., Dewulf, E.M., et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90 (2009), 1236–1243.
13. Xiong, Y., Miyamoto, N., Shibata, K., et al. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci U S A 101 (2004), 1045–1050.
14. Chimerel, C., Emery, E., Summers, D.K., et al. Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell Rep 9 (2014), 1202–1208.
15. Vogel, C.F., Goth, S.R., Dong, B., et al. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun 375 (2008), 331–335.
16. Palazzo, M., Balsari, A., Rossini, A., et al. Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion. J Immunol 178 (2007), 4296–4303.
17. Larraufie, P., Dore, J., Lapaque, N., et al. TLR ligands and butyrate increase Pyy expression through two distinct but inter-regulated pathways. Cell Microbiol, 19, 2017.
18. Kidd, M., Gustafsson, B.I., Drozdov, I., et al. IL1beta- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease. Neurogastroenterol Motil 21 (2009), 439–450.
19. Cryan, J.F., Dinan, T.G., Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13 (2012), 701–712.
20. Sampson, T.R., Mazmanian, S.K., Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17 (2015), 565–576.
21. Nayak, D., Roth, T.L., McGavern, D.B., Microglia development and function. Annu Rev Immunol 32 (2014), 367–402.
22. Nayak, D., Zinselmeyer, B.H., Corps, K.N., et al. In vivo dynamics of innate immune sentinels in the CNS. Intravital 1 (2012), 95–106.
23. Erny, D., Hrabe de Angelis, A.L., Jaitin, D., et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18 (2015), 965–977.
24. Smith, P.M., Howitt, M.R., Panikov, N., et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341 (2013), 569–573.
25. Matcovitch-Natan, O., Winter, D.R., Giladi, A., et al. Microglia development follows a stepwise program to regulate brain homeostasis. Science, 353, 2016 aad8670.
26. Khakh, B.S., Sofroniew, M.V., Diversity of astrocyte functions and phenotypes in neural circuits. Nat Neurosci 18 (2015), 942–952.
27. Rothhammer, V., Mascanfroni, I.D., Bunse, L., et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med 22 (2016), 586–597.
28. Hubbard, T.D., Murray, I.A., Bisson, W.H., et al. Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles. Sci Rep, 5, 2015, 12689.
29. Ramadoss, P., Marcus, C., Perdew, G.H., Role of the aryl hydrocarbon receptor in drug metabolism. Expert Opin Drug Metab Toxicol 1 (2005), 9–21.
30. Kennedy, P.J., Cryan, J.F., Dinan, T.G., et al. Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology 112 (2017), 399–412.
31. Jin, U.H., Lee, S.O., Sridharan, G., et al. Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities. Mol Pharmacol 85 (2014), 777–788.
32. Rasmussen, M.K., Balaguer, P., Ekstrand, B., et al. Skatole (3-methylindole) is a partial aryl hydrocarbon receptor agonist and induces CYP1A1/2 and CYP1B1 expression in primary human hepatocytes. PLoS One, 11, 2016, e0154629.
33. Kelly, J.R., Kennedy, P.J., Cryan, J.F., et al. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci, 9, 2015, 392.
34. Braniste, V., Al-Asmakh, M., Kowal, C., et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med, 6, 2014 263ra158.
35. Ivanov, I.I., Atarashi, K., Manel, N., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139 (2009), 485–498.
36. Round, J.L., Lee, S.M., Li, J., et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332 (2011), 974–977.
37. Mayer, E.A., Savidge, T., Shulman, R.J., Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology 146 (2014), 1500–1512.
38. Macfarlane, S., Dillon, J.F., Microbial biofilms in the human gastrointestinal tract. J Appl Microbiol 102 (2007), 1187–1196.
39. Desai, M.S., Seekatz, A.M., Koropatkin, N.M., et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167 (2016), 1339–1353 e21.
40. Al-Sadi, R.M., Ma, T.Y., IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol 178 (2007), 4641–4649.
41. Santos, J., Saunders, P.R., Hanssen, N.P., et al. Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat. Am J Physiol 277 (1999), G391–G399.
42. Brown, A.J., Goldsworthy, S.M., Barnes, A.A., et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278 (2003), 11312–11319.
43. Lambertsen, C.J., Wright, W.B., Multiday exposure of men to high nitrogen pressure and increased airway resistance at natural expired oxygen tension: a 14-day continuous exposure to 5.2 per cent O 2 in N 2 at 4.0 atmospheres absolute pressure. Aerosp Med 44 (1973), 826–827.
44. Varatharaj, A., Galea, I., The blood-brain barrier in systemic inflammation. Brain Behav Immun 60 (2017), 1–12.
45. Mayer, E.A., Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 12 (2011), 453–466.
46. Aguilera, M., Vergara, P., Martinez, V., Stress and antibiotics alter luminal and wall-adhered microbiota and enhance the local expression of visceral sensory-related systems in mice. Neurogastroenterol Motil 25 (2013), e515–e529.
47. Tannock, G.W., Savage, D.C., Influences of dietary and environmental stress on microbial populations in the murine gastrointestinal tract. Infect Immun 9 (1974), 591–598.
48. Van Felius, I.D., Akkermans, L.M., Bosscha, K., et al. Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil 15 (2003), 267–276.
49. Vandeputte, D., Falony, G., Vieira-Silva, S., et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65 (2016), 57–62.
50. Houlden, A., Goldrick, M., Brough, D., et al. Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production. Brain Behav Immun 57 (2016), 10–20.
51. Diaz Heijtz, R., Fetal, neonatal, and infant microbiome: perturbations and subsequent effects on brain development and behavior. Semin Fetal Neonatal Med 21 (2016), 410–417.
52. Goyal, M.S., Venkatesh, S., Milbrandt, J., et al. Feeding the brain and nurturing the mind: linking nutrition and the gut microbiota to brain development. Proc Natl Acad Sci U S A 112 (2015), 14105–14112.
53. Dominguez-Bello, M.G., Costello, E.K., Contreras, M., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 107 (2010), 11971–11975.
54. Jasarevic, E., Howerton, C.L., Howard, C.D., et al. Alterations in the vaginal microbiome by maternal stress are associated with metabolic reprogramming of the offspring gut and brain. Endocrinology 156 (2015), 3265–3276.
55. Malaspina, D., Corcoran, C., Kleinhaus, K.R., et al. Acute maternal stress in pregnancy and schizophrenia in offspring: a cohort prospective study. BMC Psychiatry, 8, 2008, 71.
56. Ronald, A., Pennell, C.E., Whitehouse, A.J., Prenatal maternal stress associated with ADHD and autistic traits in early childhood. Front Psychol, 1, 2010, 223.
57. Dominguez-Bello, M.G., De Jesus-Laboy, K.M., Shen, N., et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med 22 (2016), 250–253.
58. Backhed, F., Roswall, J., Peng, Y., et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17 (2015), 690–703.
59. Jakobsson, H.E., Abrahamsson, T.R., Jenmalm, M.C., et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut 63 (2014), 559–566.
60. Sevelsted, A., Stokholm, J., Bonnelykke, K., et al. Cesarean section and chronic immune disorders. Pediatrics 135 (2015), e92–e98.
61. Thum, C., Cookson, A.L., Otter, D.E., et al. Can nutritional modulation of maternal intestinal microbiota influence the development of the infant gastrointestinal tract?. J Nutr 142 (2012), 1921–1928.
62. Fan, W., Huo, G., Li, X., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in infants during the six months of life. J Microbiol Biotechnol 24 (2014), 133–143.
63. Roger, L.C., Costabile, A., Holland, D.T., et al. Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology 156 (2010), 3329–3341.
64. Marcobal, A., Sonnenburg, J.L., Human milk oligosaccharide consumption by intestinal microbiota. Clin Microbiol Infect 18:Suppl 4 (2012), 12–15.
65. Bauer, J., Gerss, J., Longitudinal analysis of macronutrients and minerals in human milk produced by mothers of preterm infants. Clin Nutr 30 (2011), 215–220.
66. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., et al. A core gut microbiome in obese and lean twins. Nature 457 (2009), 480–484.
67. Barrett, E., Kerr, C., Murphy, K., et al. The individual-specific and diverse nature of the preterm infant microbiota. Arch Dis Child Fetal Neonatal Ed 98 (2013), F334–F340.
68. Lloyd-Price, J., Abu-Ali, G., Huttenhower, C., The healthy human microbiome. Genome Med, 8, 2016, 51.
69. Hoban, A.E., Stilling, R.M., Ryan, F.J., et al. Regulation of prefrontal cortex myelination by the microbiota. Transl Psychiatry, 6, 2016, e774.
70. Carlson, A.L., Xia, K., Azcarate-Peril, M.A., et al. Infant gut microbiome associated with cognitive development. Biol Psychiatry 83 (2018), 148–159.
71. Palmer, C., Bik, E.M., DiGiulio, D.B., et al. Development of the human infant intestinal microbiota. PLoS Biol, 5, 2007, e177.
72. Rajilic-Stojanovic, M., Heilig, H.G., Tims, S., et al. Long-term monitoring of the human intestinal microbiota composition. Environ Microbiol, 2012 Epub ahead of print. October 15, 2012. https://doi.org/10.1111/1462-2920.12023.
73. Sowell, E.R., Peterson, B.S., Thompson, P.M., et al. Mapping cortical change across the human life span. Nat Neurosci 6 (2003), 309–315.
74. Desbonnet, L., Clarke, G., Traplin, A., et al. Gut microbiota depletion from early adolescence in mice: implications for brain and behaviour. Brain Behav Immun 48 (2015), 165–173.
75. Lurie, I., Yang, Y.X., Haynes, K., et al. Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study. J Clin Psychiatry 76 (2015), 1522–1528.
76. Dethlefsen, L., Relman, D.A., Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 108:Suppl 1 (2011), 4554–4561.
77. David, L.A., Maurice, C.F., Carmody, R.N., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
78. Smits, S.A., Leach, J., Sonnenburg, E.D., et al. Seasonal cycling in the gut microbiome of the Hadza hunter-gatherers of Tanzania. Science 357 (2017), 802–806.
79. Ong, I.M., Gonzalez, J.G., McIlwain, S.J., et al. Gut microbiome populations are associated with structure-specific changes in white matter architecture. Transl Psychiatry, 8, 2018, 6.
80. Sonnenburg, E.D., Smits, S.A., Tikhonov, M., et al. Diet-induced extinctions in the gut microbiota compound over generations. Nature 529 (2016), 212–215.
81. Wu, G.D., Chen, J., Hoffmann, C., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (2011), 105–108.
82. Tillisch, K., Labus, J., Kilpatrick, L., et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144 (2013), 1394–1401 401 e1–4.
83. Slykerman, R.F., Hood, F., Wickens, K., et al. Effect of Lactobacillus rhamnosus HN001 in pregnancy on postpartum symptoms of depression and anxiety: a randomised double-blind placebo-controlled trial. EBioMedicine 24 (2017), 159–165.
84. Pinto-Sanchez, M.I., Hall, G.B., Ghajar, K., et al. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology 153 (2017), 448–459 e8.
85. Romijn, A.R., Rucklidge, J.J., Kuijer, R.G., et al. A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression. Aust N Z J Psychiatry 51 (2017), 810–821.
86. Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., et al. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Nutrition 32 (2016), 315–320.
87. Takada, M., Nishida, K., Kataoka-Kato, A., et al. Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models. Neurogastroenterol Motil 28 (2016), 1027–1036.
88. Allen, A.P., Hutch, W., Borre, Y.E., et al. Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl Psychiatry, 6, 2016, e939.
89. Kelly, J.R., Allen, A.P., Temko, A., et al. Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects. Brain Behav Immun 61 (2017), 50–59.
90. Ostlund-Lagerstrom, L., Kihlgren, A., Repsilber, D., et al. Probiotic administration among free-living older adults: a double blinded, randomized, placebo-controlled clinical trial. Nutr J, 15, 2016, 80.
91. Schmidt, K., Cowen, P.J., Harmer, C.J., et al. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl) 232 (2015), 1793–1801.
92. Wang, H., Braun, C., Enck, P., Effects of rifaximin on central responses to social stress-a pilot experiment. Neurotherapeutics 15 (2018), 807–818.
93. Burokas, A., Arboleya, S., Moloney, R.D., et al. Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol Psychiatry 82 (2017), 472–487.
94. Desbonnet, L., Garrett, L., Clarke, G., et al. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170 (2010), 1179–1188.
95. Tarr, A.J., Galley, J.D., Fisher, S.E., et al. The prebiotics 3’Sialyllactose and 6’Sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations: evidence for effects on the gut-brain axis. Brain Behav Immun 50 (2015), 166–177.
96. Ng, Q.X., Peters, C., Ho, C.Y.X., et al. A meta-analysis of the use of probiotics to alleviate depressive symptoms. J Affect Disord 228 (2018), 13–19.
97. McKean, J., Naug, H., Nikbakht, E., et al. Probiotics and subclinical psychological symptoms in healthy participants: a systematic review and meta-analysis. J Altern Complement Med 23 (2017), 249–258.
98. Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., et al. Diversity, stability and resilience of the human gut microbiota. Nature 489 (2012), 220–230.
99. Vuong, H.E., Hsiao, E.Y., Emerging roles for the gut microbiome in autism spectrum disorder. Biol Psychiatry 81 (2017), 411–423.
100. Aarts, E., Ederveen, T.H.A., Naaijen, J., et al. Gut microbiome in ADHD and its relation to neural reward anticipation. PLoS One, 12, 2017, e0183509.
101. Sampson, T.R., Debelius, J.W., Thron, T., et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell 167 (2016), 1469–1480 e12.
102. Jiang, C., Li, G., Huang, P., et al. The gut microbiota and Alzheimer's disease. J Alzheimers Dis 58 (2017), 1–15.
103. Vogt, N.M., Kerby, R.L., Dill-McFarland, K.A., et al. Gut microbiome alterations in Alzheimer's disease. Sci Rep, 7, 2017, 13537.
104. Cattaneo, A., Cattane, N., Galluzzi, S., et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging 49 (2017), 60–68.
105. Winek, K., Engel, O., Koduah, P., et al. Depletion of cultivatable gut microbiota by broad-spectrum antibiotic pretreatment worsens outcome after murine stroke. Stroke 47 (2016), 1354–1363.
106. Wen, S.W., Wong, C.H.Y., An unexplored brain-gut microbiota axis in stroke. Gut Microbes 8 (2017), 601–606.
107. Olson, C.A., Vuong, H.E., Yano, J.M., et al. The gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell 173 (2018), 1728–1741 e13.
108. Kelly, J.R., Borre, Y., O'Brien, C., et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res 82 (2016), 109–118.
109. Zheng, P., Zeng, B., Zhou, C., et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Mol Psychiatry 21 (2016), 786–796.
110. De Palma, G., Lynch, M.D., Lu, J., et al. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med, 9, 2017.
111. Tillisch, K., Mayer, E.A., Gupta, A., et al. Brain structure and response to emotional stimuli as related to gut microbial profiles in healthy women. Psychosom Med 79 (2017), 905–913.
112. Simren, M., Barbara, G., Flint, H.J., et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 62 (2013), 159–176.
113. Labus, J.S., Hollister, E.B., Jacobs, J., et al. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome. Microbiome, 5, 2017, 49.
114. Jeffery, I.B., O'Toole, P.W., Ohman, L., et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 61 (2012), 997–1006.
115. Tap, J., Derrien, M., Tornblom, H., et al. Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology 152 (2017), 111–123 e8.
116. Chassard, C., Dapoigny, M., Scott, K.P., et al. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment Pharmacol Ther 35 (2012), 828–838.
117. Rajilic-Stojanovic, M., Biagi, E., Heilig, H.G., et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141 (2011), 1792–1801.
118. Bailey, M.T., Dowd, S.E., Galley, J.D., et al. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun 25 (2011), 397–407.
119. Galley, J.D., Nelson, M.C., Yu, Z.T., et al. Exposure to a social stressor disrupts the community structure of the colonic mucosa-associated microbiota. BMC Microbiol, 14, 2014, 189.
120. Knowles, S.R., Nelson, E.A., Palombo, E.A., Investigating the role of perceived stress on bacterial flora activity and salivary cortisol secretion: a possible mechanism underlying susceptibility to illness. Biol Psychol 77 (2008), 132–137.
121. Pedram, P., Wadden, D., Amini, P., et al. Food addiction: its prevalence and significant association with obesity in the general population. PLoS One, 8, 2013, e74832.
122. Lin, H.V., Frassetto, A., Kowalik, E.J. Jr., et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One, 7, 2012, e35240.
123. Everard, A., Lazarevic, V., Derrien, M., et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60 (2011), 2775–2786.
124. Osadchiy, V., Labus, J.S., Gupta, A., et al. Correlation of tryptophan metabolites with connectivity of extended central reward network in healthy subjects. PLoS One, 13, 2018, e0201772.
125. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
126. Vijay-Kumar, M., Aitken, J.D., Carvalho, F.A., et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328 (2010), 228–231.
127. Fernandez-Real, J.M., Serino, M., Blasco, G., et al. Gut microbiota interacts with brain microstructure and function. J Clin Endocrinol Metab 100 (2015), 4505–4513.
128. Zhang, H., DiBaise, J.K., Zuccolo, A., et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 106 (2009), 2365–2370.
129. Li, J.V., Ashrafian, H., Bueter, M., et al. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 60 (2011), 1214–1223.
130. Damms-Machado, A., Mitra, S., Schollenberger, A.E., et al. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed Res Int, 2015, 2015, 806248.
131. Furet, J.P., Kong, L.C., Tap, J., et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59 (2010), 3049–3057.
132. Graessler, J., Qin, Y., Zhong, H., et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J 13 (2013), 514–522.
133. Liou, A.P., Paziuk, M., Luevano, J.M. Jr., et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med, 5, 2013, 178ra41.
134. Tremaroli, V., Karlsson, F., Werling, M., et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab 22 (2015), 228–238.
135. Borre, Y.E., O'Keeffe, G.W., Clarke, G., et al. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med 20 (2014), 509–518.